140 related articles for article (PubMed ID: 10620725)
21. Effects of surfactant characteristics on drug availability from suppositories.
Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
[TBL] [Abstract][Full Text] [Related]
22. Ketoprofen suppository dosage forms: in vitro release and in vivo absorption studies in rabbits.
Babar A; Bellete T; Plakogiannis FM
Drug Dev Ind Pharm; 1999 Feb; 25(2):241-5. PubMed ID: 10065359
[TBL] [Abstract][Full Text] [Related]
23. Influence of interfacial rheological properties of mixed emulsifier films on the stability of water-in-oil-in-water emulsions.
Opawale FO; Burgess DJ
J Pharm Pharmacol; 1998 Sep; 50(9):965-73. PubMed ID: 9811156
[TBL] [Abstract][Full Text] [Related]
24. Effects of non-ionic surfactants on isotachophoretic separations of 2-arylpropionic acids.
Sádecká J; Cakrt M
J Chromatogr A; 2005 Aug; 1084(1-2):152-9. PubMed ID: 16114248
[TBL] [Abstract][Full Text] [Related]
25. Effect of bioadhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether, and method of preparation on the relative hypoglycemia produced by insulin enteric-coated capsules in diabetic beagle dogs.
Hosny EA; al-Shora HI; Elmazar MM
Drug Dev Ind Pharm; 2002 May; 28(5):563-70. PubMed ID: 12098845
[TBL] [Abstract][Full Text] [Related]
26. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
27. Etoposide (VP-16) uptake by tumour spheroids and activity in the presence of Brij 30, formulation additives and sodium salicylate.
Cook JM; Florence AT; Russell J; Wheldon TE
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):311-8. PubMed ID: 2702985
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
29. Formulation and in vitro evaluation of self-emulsifying formulations of Cinnarizine.
Vithlani S; Sarraf S; Chaw CS
Drug Dev Ind Pharm; 2012 Oct; 38(10):1188-94. PubMed ID: 22196372
[TBL] [Abstract][Full Text] [Related]
30. Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo.
Fakhar-Ud-Din ; Khan GM
Pharm Dev Technol; 2019 Jan; 24(1):63-69. PubMed ID: 29251521
[TBL] [Abstract][Full Text] [Related]
31. Rectal Administration of Celecoxib Liquid Suppositories with Enhanced Bioavailability and Safety in Rats.
Jiao Y; Xie S; Baseer A; Ud-Din F
Curr Drug Deliv; 2023; 20(2):201-210. PubMed ID: 35570559
[TBL] [Abstract][Full Text] [Related]
32. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
Bećirević M; Petricić V; Kallay N
Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
[TBL] [Abstract][Full Text] [Related]
33. Micellar-enhanced ultrafiltration of copper ions using sodium dodecyl sulfate and its mixture with Brij 35, Tween 80 and Triton X-100.
Zhao B; Li R; Zhong J; Zhang L
Water Sci Technol; 2013; 67(10):2154-9. PubMed ID: 23676382
[TBL] [Abstract][Full Text] [Related]
34. Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres.
Thakare M; Israel B; Garner S; Ahmed H; Elder D; Capomacchia A
Pharm Dev Technol; 2017 May; 22(3):418-425. PubMed ID: 27499352
[TBL] [Abstract][Full Text] [Related]
35. Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories.
Chicco D; Grabnar I; Skerjanec A; Vojnovic D; Maurich V; Realdon N; Ragazzi E; Belic A; Karba R; Mrhar A
Int J Pharm; 1999 Nov; 189(2):147-60. PubMed ID: 10536243
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of rectal absorption of insulin using salicylates in dogs.
Nishihata T; Rytting JH; Kamada A; Higuchi T; Routh M; Caldwell L
J Pharm Pharmacol; 1983 Mar; 35(3):148-51. PubMed ID: 6132970
[TBL] [Abstract][Full Text] [Related]
37. Formulation development and release studies of indomethacin suppositories.
Sah ML; Saini TR
Indian J Pharm Sci; 2008; 70(4):498-501. PubMed ID: 20046779
[TBL] [Abstract][Full Text] [Related]
38. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
Kim JY; Ku YS
Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
[TBL] [Abstract][Full Text] [Related]
39. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
40. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions.
Mura P; Faucci MT; Manderioli A; Bramanti G; Parrini P
Drug Dev Ind Pharm; 1999 Mar; 25(3):257-64. PubMed ID: 10071817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
